共 85 条
[1]
Andersson Y(2018)Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 JAMA Oncol 1 1553-1568
[2]
Bergkvist L(2018)Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes Breast Cancer Res Treat 171 359-369
[3]
Frisell J(2020)Biological characteristics and long-term outcomes in node-negative breast cancer Clin Breast Cancer 20 183-191
[4]
Boniface J(2007)Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2–40 in node negative breast cancer Mod Pathol 321 288-300
[5]
Agostinetto E(2019)Breast cancer treatment: a review JAMA 165 743-750
[6]
Giordano L(2017)Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2 and T3 tumors Breast Cancer Res Treat 5 41-386
[7]
Torrisi R(2019)Ten-year clinical outcomes in N0 ER+ breast cancer patients with recurrence score-guided therapy NPJ Breast Cancer 6 370-597
[8]
De Sanctis R(2016)Podoplanin-a small glycoprotein with many faces Am J Cancer Res 8 577-214
[9]
Masci G(2018)Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment Cancer Metastasis Rev 12 e0184970-499
[10]
Losurdo A(2017)Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: a possible role for cancer-associated fibroblasts in breast cancer progression PLoS ONE 37 207-2722